WuXi PharmaTech (NYSE: WX) Holds Its Second Life Science and Chemistry Awards Ceremony in Beijing
Dec 18, 2008
December 18, 2008 - Shanghai, China - WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology, medical device research and development outsourcing company with operations in China and the United States, announced today that the company successfully held its second Life Science and Chemistry Awards Ceremony on December 7, 2008 at the Great Hall of the People, Beijing, China.
With the whole process starting in July, the second "WuXi PharmaTech Life Science and Chemistry Award" set the scope of the selection as preclinical pharmacology and toxicology. This year's selection panel was comprised of eleven scholars with industry expertise. Dr. Sang Guowei, Vice Chairman of the Standing Committee of the National People's Congress, served as Chairman of the selection panel. Other panel members included Dr. Wang Li, Professor of Sichuan University and Director of Chendu Traditional Chinese Medicine Safety Evaluation Center, Dr Li Bo, Director of the National Center for Safety Evaluation of Drugs, Dr. Li Ge, Chairman and Chief Executive Officer of WuXi PharmaTech, Dr. Zhang Yongxiang, Vice Director of the Science and Technology Department of Academy of Military Medical Sciences and Researcher of Research Institute of Drugs and Toxicants, Dr. Chen Kaixian, President of the Shanghai University of Traditional Chinese Medicine and Academician of Chinese Academy of Sciences, Dr. Chen Shuhui, Chief Scientific Officer of WuXi PharmaTech, Dr. Lin Guoqiang, Professor of the Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences and Academician of Chinese Academy of Sciences, Dr. Zhou Honghao, Professor of Central South University and Academician of Chinese Academy of Engineering, Dr. Yuan Bojun, QA Director and Professor of New Drug Safety Evaluation of Second Military Medical University, and Dr. Liao Mingyang, Director of National Beijing Center of New Drug Safety Evaluation Research of Research Institute of Drugs and Toxicants of Academy of Military Medical Sciences.
Twelve winners were selected through rigorous, objective and transparent evaluation. Dr. Wang Guangji, Vice President of China Pharmaceutical University, won the Special Prize. The First Prize winners are Dr. Ren Jin, Director of Safety Evaluation Center of Shanghai Institute of Materia Medica, Chinese Academy of Sciences and Dr. Li Chuan, Researcher of Shanghai Institute of Materia Medica Chinese Academy of Sciences. The Second Prize winners are Dr. Ma Jin, Director of the National Shanghai Center for New Drug Safety Evaluation and Research, Dr. Zhu Yichun, Professor of Fudan University, Dr. Lu Guocai, Director of New Drug Safety Evaluation of Second Military Medical University, and Dr. Guo Qinglong, Professor of Department of Physiology of China Pharmaceutical University. The Third Prize winners are Dr. Wang Quanjun, Vice Group Leader of the General Toxicology Group of the National Beijing Center for New Drug Safety Evaluation Research of Research Institute of Drugs and Toxicants of Academy of Military Medical Sciences, Dr. Mao Yu, Researcher of New Drug Safety Evaluation of Second Military Medical University, Dr. Yang Jingyu, Associate Dean for Life Science and Biopharmaceuticals in Shenyang Pharmaceutical University, Dr. Jiang Dejian, Vice Researcher of the Department of Pharmacology of Pharmaceutical Faculty in Central South University and Dr. Ju Zhenyu, Associate Professor of the Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences.
"I am honored to receive the 'WuXi PharmaTech Life Science and Chemistry Award'. This award recognizes my research work and further spurs me to put my heart and soul into pharmaceutical research and development. WuXi, as a leading pharmaceutical, biotechnology and medical device research and development outsourcing company, founded this award to support and inspire those who engage in pharmaceutical research and development and promote our basic scientific research and innovation related to life science and chemistry." commented Dr. Wang Guangji, the Special Prize winner, Vice President of China Pharmaceutical University.
Dr. Sang Guowei, Vice Chairman of the Standing Committee of the National People's Congress, and Mr. Zhang Huaixi, Vice Chairman of the Tenth Chinese People's Political Consultative Conference attended the awards ceremony, presented the awards to the winners, and had a warm talk with them, encouraging them to make more contributions to China's pharmaceutical research and scientific development.
The second "WuXi PharmaTech Life Science and Chemistry Award" received great support from the Tianjin Economic-Technological Development Area and Suzhou Wuzhong District.
"We are honored to hold the second 'WuXi PharmaTech Life Science and Chemistry Award'. Without a robust talent pool available in China, without the support from our society, it is impossible for WuXi to achieve today's achievements. We hereby want to express our sincere gratitude to all of those who support WuXi. We hope this award will continually drive the scientific innovation and help to transform the drug research and development, thus ultimately to improve and save lives." commented Dr. Ge Li, Chairman and Chief Executive Officer of WuXi PharmaTech.
About WuXi PharmaTech Life Science and Chemistry Award
The WuXi PharmaTech Life Science and Chemistry Award was approved and endorsed by the National Office of Science and Technology Awards in February, 2007, designed to promote China's scientific and technological development. WuXi PharmaTech will reward young professionals of Chinese citizenship who make an outstanding achievement in the field of chemistry, biology, or other life science related disciplines. Each year the scope of the award selection will be settled on chemistry, toxicology, biology, pharmacology or one of the related fields.
WuXi PharmaTech provides one million RMB to fund such an annual award beginning in 2007. The Special Prize winners, First Prize winners, Second Prize winners and Third Prize winners will get a reward of 200,000 RMB, 100,000 RMB, 50,000 RMB and 20,000 RMB respectively.
In the first half of the calendar year the award organization settles
the scope of the award selection and announces the selection procedure
on the corporate website and in related academic journals. Applications
are accepted through both individual submission and recommendations by
scholars and professors in the related fields. In the second half of the
calendar year a selection panel is built to conduct the award selection
and the company will hold the awards ceremony at the end of the year.
About WuXi PharmaTech (Cayman) Inc.
WuXi PharmaTech is a leading pharmaceutical, biotechnology and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focused company, WuXi PharmaTech provides pharmaceutical, biotechnology and medical device companies a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. WuXi PharmaTech's services are designed to assist its global partners in shortening the cycle and lowering the cost of drug and medical device R&D. The operating subsidiaries of WuXi PharmaTech are known as WuXi AppTec. For more information, please visit: www.wuxiapptec.com.